[Present status in and future prospects for development of protein function inhibitors for gynecologic neoplasms].
Wake
Norio
N
Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University.
D016922:Cellular Senescence / Q000235:genetics; D050756:Cyclin-Dependent Kinase Inhibitor Proteins / Q000502:physiology; D015195:Drug Design; D047628:Estrogen Receptor alpha / Q000502:physiology; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D006801:Humans; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D025803:Tumor Suppressor Protein p14ARF / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000502:physiology
D050756:Cyclin-Dependent Kinase Inhibitor Proteins; D047628:Estrogen Receptor alpha; D025803:Tumor Suppressor Protein p14ARF; D016159:Tumor Suppressor Protein p53